Galectin Therapeutics Inc (GALT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GALT Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Galectin Therapeutics Inc adapts its asset base and funding mix.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent13.27
Cash, Cash Equivalents Other0.01
Cash & Short-term Investments13.00
Prepaid Expense And Other Assets Current1.39
Total Current Assets14.66
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent0.17
Total Assets14.83
Liabilities
Accounts Payable, Current AC3.73
Accrued Liabilities, Current AC3.99
Derivative Liability, Current DE6.14
Other Liabilities, Current137.76
Total Current Liabilities151.62
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.00
Other liabilities, Noncurrent0.06
Convertible Note Payable And Accrued Interest Net Of Debt Discount Related Party Current-
Total Liabilities151.68
Stockholders' Equity
Common Stock Value0.07
Additional Paid In Capital Common Stock307.67
Retained Earnings / Accumulated Deficit-446.79
Other Equity0.00
Common Stockholder's Equity-11,051.78
Preferred Stockholder's Equity1,185.48
Non-controlling interests & other9,727.72
Total Stockholder's Equity-138.58
Liabilities & Stockholder's Equity14.83
4 historic quarters locked

Sign in to unlock the full Galectin Therapeutics Inc balance sheet history.

About Galectin Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001140361-26-032945

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.